Search research articles
Contact Us
Filters
Showing results (201-210 of 225) with videos related to
Page
of 23
Sort By:
Proteomics. Clinical Applications
|
November 2, 2016
Aberrant cytokine secretion and zinc uptake in chronic cadmium-exposed lung epithelial cells
Yan-Ming Xu, Yang-Min Gao, Dan-Dan Wu, et al.
Biochimica Et Biophysica Acta
|
July 21, 2015
Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop
Ze-Peng Du, Bing-Li Wu, Yang-Min Xie, et al.
The International Journal of Biochemistry & Cell Biology
|
May 16, 2017
Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation
Li-Yan Li, Ying-Hua Xie, Yang-Min Xie, et al.
The Oncologist
|
December 14, 2018
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy
Daniel L Suzman, Sundeep Agrawal, Yang-Min Ning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 24, 2013
Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summary
Paul G Kluetz, Yang-Min Ning, V Ellen Maher, et al.
CNS Neuroscience & Therapeutics
|
March 15, 2024
Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic stroke
Rong-Liang Wang, Zhen-Hong Yang, Yu-You Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2019
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody
V Ellen Maher, Laura L Fernandes, Chana Weinstock, et al.
Human Pathology
|
March 17, 2016
SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma
Ying Zhu, Meng-Xiao Zhu, Xiao-Dan Zhang, et al.
Journal of Proteomics
|
February 10, 2015
Quantitative proteomics reveals the downregulation of GRB2 as a prominent node of F806-targeted cell proliferation network
Li-Yan Li, Kai Zhang, Hong Jiang, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 24, 2017
L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription
Jin-Cheng Guo, Yang-Min Xie, Li-Qiang Ran, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 225) with videos related to
Sort By:
Page
of 23
Proteomics. Clinical Applications
|
November 2, 2016
Aberrant cytokine secretion and zinc uptake in chronic cadmium-exposed lung epithelial cells
Yan-Ming Xu, Yang-Min Gao, Dan-Dan Wu, et al.
Biochimica Et Biophysica Acta
|
July 21, 2015
Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop
Ze-Peng Du, Bing-Li Wu, Yang-Min Xie, et al.
The International Journal of Biochemistry & Cell Biology
|
May 16, 2017
Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation
Li-Yan Li, Ying-Hua Xie, Yang-Min Xie, et al.
The Oncologist
|
December 14, 2018
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy
Daniel L Suzman, Sundeep Agrawal, Yang-Min Ning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 24, 2013
Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summary
Paul G Kluetz, Yang-Min Ning, V Ellen Maher, et al.
CNS Neuroscience & Therapeutics
|
March 15, 2024
Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic stroke
Rong-Liang Wang, Zhen-Hong Yang, Yu-You Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2019
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody
V Ellen Maher, Laura L Fernandes, Chana Weinstock, et al.
Human Pathology
|
March 17, 2016
SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma
Ying Zhu, Meng-Xiao Zhu, Xiao-Dan Zhang, et al.
Journal of Proteomics
|
February 10, 2015
Quantitative proteomics reveals the downregulation of GRB2 as a prominent node of F806-targeted cell proliferation network
Li-Yan Li, Kai Zhang, Hong Jiang, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 24, 2017
L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription
Jin-Cheng Guo, Yang-Min Xie, Li-Qiang Ran, et al.
Page
of 23